Breaking News Instant updates and real-time market news.

UTX

United Technologies

$124.51

-0.5 (-0.40%)

, WYNN

Wynn Resorts

$190.92

-0.71 (-0.37%)

16:49
05/15/18
05/15
16:49
05/15/18
16:49

Third Point takes large position in United Technologies, exits Aetna stake

Third Point disclosed in an SEC filing its holdings as of March 31, 2018. Third Point's eleven new buys during the first quarter included, by size of position, United Technologies (UTX), Wynn Resorts (WYNN), Pagseguro (PAGS), Electronic Arts (EA), and Marathon Petroleum (MPC). Third Point exited sixteen positions during the quarter, including by size of previous position, Aetna (AET), NXP Semiconductors (NXPI), FMC Corp (FMC), and Honeywell (HON). Third Point increased its stake in seven holdings, including by size of previous position, Anthem (ANTM), Worldpay (WP), Facebook (FB), Lennar (LEN), and Vulcan Materials (VMC). Third Point reduced its stake in fourteen holdings, including by size of previous position, Alibaba (BABA), Alphabet (GOOGL), Mohawk (MHK), and Constellation Brands (STZ). Third Point's top holdings as of March 31, in order of size, were Baxter (BAX), United Technologies, Alibaba, Facebook, and Alphabet.

UTX

United Technologies

$124.51

-0.5 (-0.40%)

WYNN

Wynn Resorts

$190.92

-0.71 (-0.37%)

PAGS

PagSeguro Digital

$32.21

-0.36 (-1.11%)

EA

Electronic Arts

$130.11

-2.43 (-1.83%)

MPC

Marathon Petroleum

$77.28

-0.59 (-0.76%)

AET

Aetna

$177.07

-0.8 (-0.45%)

NXPI

NXP Semiconductors

$110.10

-0.63 (-0.57%)

FMC

FMC Corporation

$89.97

0.23 (0.26%)

HON

Honeywell

$147.34

0.07 (0.05%)

ANTM

Anthem

$230.86

-1.37 (-0.59%)

WP

Worldpay

$81.75

0.81 (1.00%)

FB

Facebook

$184.30

-2.38 (-1.27%)

LEN

Lennar

$51.21

-3.06 (-5.64%)

VMC

Vulcan Materials

$127.38

0.58 (0.46%)

GOOGL

Alphabet Class A

$1,084.87

-21.7 (-1.96%)

MHK

Mohawk

$209.05

-1.63 (-0.77%)

STZ

Constellation Brands

$221.75

-0.05 (-0.02%)

BAX

Baxter

$70.45

-0.76 (-1.07%)

  • 15

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 18

    May

  • 21

    May

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 13

    Jun

  • 25

    Jun

UTX United Technologies
$124.51

-0.5 (-0.40%)

05/08/18
DAIW
05/08/18
UPGRADE
DAIW
Outperform
United Technologies upgraded to Outperform from Hold at Daiwa
02/15/18
LEHM
02/15/18
INITIATION
Target $157
LEHM
Overweight
United Technologies initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started United Technologies with an Overweight rating and $157 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
03/15/18
UBSW
03/15/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up not worth disruption, says UBS
UBS analyst Steven Winoker said he does not think it is worth breaking up United Technologies at this point as it will not be worth the disruption in business and he sees only a slight increase in the sum-of-the-parts valuation. However, he still sees roughly 20% upside in the shares. Winoker reiterated his Buy rating and $155 price target on United Technologies shares.
03/19/18
UBSW
03/19/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up likely unless stock rallies significantly, says UBS
A break-up of United Technologies is likely unless the stock appreciates significantly, UBS analyst Steven Winoker tells investors in a research note following the company's investor day. The analyst's break-up valuation improved to $154 per share at the current midpoint, from $146 last week, following United's comments. Winoker does see advantages to United Technologies' scale as one company and has concerns "with potential disruption/ inefficiencies," but he adds: "at the end of the day, we think UTX will break-up if its value is not realized in its current form." The analyst keeps a Buy rating on the shares with a $155 price target.
WYNN Wynn Resorts
$190.92

-0.71 (-0.37%)

04/02/18
04/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Hold from Underperform at Jefferies with analyst Philippe Houchois saying Tesla shares are down 32% from their September 2017 peak and he sees a "high probability" that management and the board, when releasing first quarter unit data this week, take "more drastic action" on guidance and funding to "restore credibility." 2. Allstate (ALL) upgraded to Market Perform from Underperform at Keefe Bruyette with analyst Meyer Shields expecting strong first quarter results from the company. 3. Discovery (DISCA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying she believes the stock offers a "compelling" risk/reward profile at current share levels. 4. Darden (DRI) was upgraded to Outperform from Sector Perform at RBC Capital and to Outperform from Market Perform at Raymond James. 5. Wynn Resorts (WYNN) upgraded to Buy from Neutral at Roth Capital with analyst David Bain saying he views regulatory and other risks as diminished, with Massachusetts likely remaining as the largest one still outstanding. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/18
ROTH
04/02/18
UPGRADE
Target $206
ROTH
Buy
Wynn Resorts upgraded to Buy from Neutral at Roth Capital
Roth Capital analyst David Bain upgraded Wynn Resorts to Buy from Neutral as he views regulatory and other risks as diminished, with Massachusetts likely remaining as the largest one still outstanding. While the analyst does not believe the "Steve Wynn stock multiple premium" will return, fundamental underpinnings are too strong for shares to not retrace at least closer to historical stock multiple averages in the near-to-intermediate term. Bain also raised his price target on the shares to $206 from $170.
04/25/18
NOMU
04/25/18
NO CHANGE
Target $215
NOMU
Buy
Wynn Resorts price target raised to $215 from $210 at Nomura Instinet
Nomura Instinet analyst Harry Curtis raised his price target for Wynn Resorts to $215 saying the Q1 results were even stronger than pre-announcement six weeks ago would have suggested. The analyst sees 19% total return upside potential relative to the stock's 3% post-earnings pullback. He keeps a Buy rating on Wynn.
04/25/18
JEFF
04/25/18
NO CHANGE
Target $230
JEFF
Buy
Wynn Resorts price target raised to $230 from $200 at Jefferies
Jefferies analyst David Katz raised his price target for Wynn Resorts to $230 saying last night's quarter offered little reason to change his positive stance on the shares. Management indicated its plans for "aggressive but prudent growth" with continued consideration of the full spectrum of capital allocation options, which is not a surprise, Katz tells investors in a post-earnings research note titled "WYNN 2.0: Same Hardware, Software Reboot." The analyst reiterates a Buy rating on Wynn Resorts.
PAGS PagSeguro Digital
$32.21

-0.36 (-1.11%)

05/03/18
SBSH
05/03/18
INITIATION
Target $24
SBSH
Sell
PagSeguro Digital initiated with a Sell at Citi
Citi started PagSeguro Digital with a Sell rating and $24 price target.
03/12/18
SUSQ
03/12/18
UPGRADE
SUSQ
Positive
PagSeguro Digital upgraded to Positive from Neutral at Susquehanna
03/12/18
SUSQ
03/12/18
UPGRADE
Target $41
SUSQ
Positive
PagSeguro Digital upgraded to Positive at Susquehanna
As previously reported, Susquehanna analyst James Friedman upgraded PagSeguro Digital to Positive from Neutral. The analyst said its results led him to believe hypergrowth may be sustainable mid-term as merchant growth, increased sales per merchant, and a modest reduction in "take rates" makes Brazil one of the most exciting countries for payments. Friedman raised his price target to $41 from $31 on PagSeguro Digital shares.
03/05/18
FBCO
03/05/18
INITIATION
Target $34
FBCO
Neutral
PagSeguro Digital initiated with a Neutral at Credit Suisse
Credit Suisse analyst Lucas Lopes started PagSeguro Digital with a Neutral rating and $34 price target. The analyst believes the shares are "priced to perfection" and notes the company's high growth has attracted competition.
EA Electronic Arts
$130.11

-2.43 (-1.83%)

05/09/18
STFL
05/09/18
NO CHANGE
Target $141
STFL
Buy
Electronic Arts guidance looks conservative, says Stifel
Stifel analyst Drew Crum said he thinks Electronic Arts reported a "solid end" to FY18 and he believes the company's in-line FY19 guidance appears conservative given he sees the company entering a period of accelerating growth. Crum maintains his Buy rating and $141 price target on EA shares.
05/09/18
MKMP
05/09/18
NO CHANGE
Target $144
MKMP
Buy
Electronic Arts price target raised to $144 from $137 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Electronic Arts to $144 and kept his Buy rating after the company's "solid" Q4 earnings beat "across all key metrics". The analyst further notes that the company's initiated FY19 non-GAAP EPS view of $4.85 was likely "conservative" and sees "multiple levers" that can drive its outperformance.
05/09/18
BARD
05/09/18
NO CHANGE
Target $148
BARD
Outperform
Electronic Arts results driven by strong digital performance, says Baird
Baird analyst Colin Sebastian said the Electronic Arts Q4 results were once again driven by the strength of its digital and the ongoing strength of live services. He said the strength is consistent with the company's long-term growth initiatives. Sebastian reiterated his Outperform rating and $148 price target on Electronic Arts shares.
05/09/18
OPCO
05/09/18
NO CHANGE
Target $140
OPCO
Outperform
Electronic Arts price target raised to $140 from $130 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his price target for Electronic Arts to $140 from $130 after another "solid" quarter. The analyst believes the company is in a "solid position" to keep delivering high-single/double-digits net booking/non-GAAP EPS growth with free cash flow of $1.8B per year. Uerkwitz reiterates an Outperform rating on the shares.
MPC Marathon Petroleum
$77.28

-0.59 (-0.76%)

05/10/18
SBSH
05/10/18
UPGRADE
Target $22
SBSH
Buy
CVR Refining upgraded to Buy from Neutral at Citi
Citi analyst Prashant Rao upgraded CVR Refining (CVRR) to Buy with a $22 price target. Midland crude differentials are poised to hit $15, and Permian-focused refiners stand to make outsized cash flow gains, Rao tells investors in a research note. The analyst also reiterates a Buy rating on Valero (VLO) and raised his price target on the shares to $129. He calls Marathon Petroleum (MPC) his new top Refining pick with a $95 price target.
05/10/18
SBSH
05/10/18
DOWNGRADE
SBSH
Neutral
Andeavor downgraded to Neutral from Buy at Citi
Citi analyst Prashant Rao downgraded Andeavor (ANDV) to Neutral citing the proposed takeover by Marathon Petroleum (MPC). The analyst is constructive on the merger.
05/10/18
BOFA
05/10/18
UPGRADE
Target $95
BOFA
Buy
Marathon Petroleum upgraded to Buy on higher Brent outlook at BofA/Merrill
As previously reported, BofA/Merrill upgraded Marathon Petroleum to Buy from Neutral and raised its price target to $95 from $88. Leggate raised his long-term Brent price forecast to $65/bbl from $60/bbl and believes Marathon is poised to deliver solid free cash flow and growth in 2018, easily reaching growth targets. The analyst sees upside in the Bakken and views it as a catalyst for improving oil margins, combined with a reemergence in Eagle Ford production differentials. Leggate also like Marathon's valuation, cash balance, and improved disclosures.
05/14/18
05/14/18
DOWNGRADE

Neutral
Andeavor downgraded to Neutral after takeover pact at JPMorgan
As previously reported, JPMorgan analyst Phil Gresh downgraded Andeavor (ANDV) to Neutral citing the proposed takeover by Marathon Petroleum (MPC).
AET Aetna
$177.07

-0.8 (-0.45%)

05/02/18
05/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Juniper was (JNPR) upgraded to Buy from Neutral at BofA/Merrill and to Hold from Sell at Deutsche Bank. 2. Aetna (AET) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Steven Halper saying he views the risk/reward on shares as "more compelling" following the company's first quarter results. 3. Freeport McMoRan (FCX) upgraded to Outperform from Neutral at CIBC with analyst Oscar Cabrera saying shares have dropped over 20% following the Q1 report, reflecting a worst-case scenario for the Indonesia scenario. 4. Shutterfly (SFLY) upgraded to Neutral from Sell at Goldman Sachs with analyst Christopher Merwin citing the better than expected Q1 report. 5. CommScope (COMM) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux saying he believes the company's unique mix of exposure to Tier 1 carrier investment in both fiber optic and 4G/5G wireless infrastructure offers compelling value following the sharp pullback in shares after only a "fairly modest" cut to its EPS expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/18
LEER
04/17/18
NO CHANGE
LEER
Amazon, Trump news positive for drug supply chain, distributors, says Leerink
Leerink analyst Ana Gupte sees the dual pronged news flow on Amazon (AMZN) being unlikely to enter the Hospital drug supply chain, and President Trump poised to give a speech on drug pricing and supply chain reform on April 26 as HHS Secretary Alex Azar solicits ideas for pricing reform as positive for both the drug supply chain across PBMs and drug distributors and biopharma manufacturers that have been roiled by fears of margin compression on both these threats. Within her coverage, the analyst views this as positive for UnitedHealth (UNH) with its Optum Rx PBM, Cigna (CI) with its deal to acquire Express Scripts (ESRX), and Aetna (AET) which has inked a deal with CVS (CVS) in part through equity, as well as Anthem (ANTM) with IngenioRx and Humana (HUM) with or without its potential Walmart (WMT) deal that has a sizable mail order operation.
05/01/18
CANT
05/01/18
UPGRADE
CANT
Overweight
Aetna upgraded to Overweight from Neutral at Cantor Fitzgerald
05/02/18
CANT
05/02/18
UPGRADE
Target $202
CANT
Overweight
Cantor upgrades Aetna to Overweight on 'compelling' risk/reward
Cantor Fitzgerald analyst Steven Halper last night upgraded Aetna to Overweight from Neutral with a price target of $202. The stock closed yesterday down 75c to $178.71. The analyst views the risk/reward on shares as "more compelling" following the company's Q1 results.
NXPI NXP Semiconductors
$110.10

-0.63 (-0.57%)

05/03/18
DRXL
05/03/18
UPGRADE
DRXL
Buy
NXP Semiconductors upgraded to Buy from Hold at Drexel Hamilton
05/03/18
RHCO
05/03/18
NO CHANGE
Target $119
RHCO
Buy
NXP quarter does not confirm bear thesis, says SunTrust
SunTrust analyst William Stein says NXP Semiconductors' (NXPI) miss in Q1, while a bad print, does not confirm the bear thesis on the shares, which he believes centers around a "disengaged management team and a broken product portfolio." Despite the Q1 miss management remains engaged, and the product portfolio "remains robust," Stein tells investors in a post-earnings research note. He thinks management will only demonstrate engagement if the Qualcomm (QCOM) deal breaks. The analyst lowered his price target for NXP Semiconductors to $119 from $121 and keeps a Buy rating on the shares.
05/03/18
05/03/18
UPGRADE
Target $127.5

Buy
NXP Semiconductors upgraded to Buy on deal closure optimism at Drexel Hamilton
As previously reported, Drexel Hamilton analyst Cody Acree upgraded NXP Semiconductors (NXPI) to Buy from Hold, citing his optimism about the company closing its merger with Qualcomm (QCOM). While still working to satisfy MOFCOM regulatory approval, NXP reported results that were largely in-line with his seasonal expectations and consistent with the positive industry trends being seen from most of the analog group, Acree tells investors. He raised his price target on NXP shares to $127.50 from $110.
05/03/18
BERN
05/03/18
NO CHANGE
Target $115
BERN
Market Perform
NXP Semiconductors price target lowered to $115 from $125 at Bernstein
Bernstein analyst Stacy Rasgon lowered her price target for NXP Semiconductors to $115 from $125 after its Q1 results missed. The analyst reiterates a Market Perform rating on the shares.
FMC FMC Corporation
$89.97

0.23 (0.26%)

05/14/18
05/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Buy from Neutral at BofA/Merrill with analyst Ken Hoexter saying he thinks UPS's Network Transformation plan that will be launched in a couple months will improve its cost structure and margins, and could prove to be the turning point for the company and drive the multiple back toward historical levels. 2. FMC Corporation (FMC) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the solid first quarter report convinced him to change his rating as pro forma orgnaic growth rates were very strong, and earnings contribution from the DowDuPont (DWDP) acquisition far exceeded his expectations. 3. L Brands (LB) upgraded to Buy from Neutral at Citi with analyst Paul Lejuez saying he acknowledges this is "not an 'all's clear' type of call," and that things may get worse before they get better, however, he feels consensus sentiment has become so bearish and the stock's valuation is "just too cheap to ignore." 4. Lear (LEA) upgraded to Outperform from In Line at Evercore ISI with analyst Chris McNally saying he sees double digit earnings growth through 2020 with earnings growth set to accelerate in 2019 on the back of the GM truck launch and acceleration of E-Systems given megatrends in Electrification & Connectivity. 5. CSX (CSX) upgraded to Neutral from Sell at Goldman Sachs with analyst Matt Reustle citing better risk/reward following successful execution of Q1 network initiatives. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/04/18
FBCO
05/04/18
NO CHANGE
Target $107
FBCO
Outperform
Credit Suisse 'comfortably in the bull camp' on FMC shares
Credit Suisse analyst Christopher Parkinson said he is "comfortably in the bull camp" on FMC Corporation shares following the company's Q1 results, telling investors in a research note that FMC has "multiple levers" to pull to generate above-market growth throughout the 2018-2018 period. He notes that most of his bull thesis is contingent on these levers, including cross-selling, new products and registration and enhanced distribution, which could drive high single digit revenue growth through 2020. Parkinson reiterated an Outperform rating and raised his price target to $107 from $100.
05/14/18
GSCO
05/14/18
UPGRADE
GSCO
Buy
FMC Corporation upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Robert Koort upgraded FMC Corp. to Buy from Neutral and raised its price target to $114 from $99. Koort said the solid Q1 report convinced him to change his rating as pro forma orgnaic growth rates were very strong,and earnings contribution from the DowDuPont acquisition far exceeded his expectations. The analyst expects FMC's 2018 earnings to top guidance and for 2019/20 to see double-digit earnings growth. Koort is also encouraged by corn prices that are nearing a two-year high, which has historically been a leading indicator of crop protection sales growth.
05/11/18
NOMU
05/11/18
NO CHANGE
Target $130
NOMU
Buy
Albemarle price target lowered to $130 from $141 at Nomura Instinet
Nomura Instinet analyst Aleksey Yefremov lowered his price target for Albemarle (ALB) to $130 and keeps a Buy rating on the shares. The company's Q1 results, while "solid," failed to point to "immediate and meaningful upside earnings revision in Lithium," Yefremov tells investors in a research note. The analyst still sees upside optionality to Albemarle's high-single-digit 2018 lithium price guidance, but notes the pace of increases will likely trail FMC Corporation (FCM) and SQM (SQM).
HON Honeywell
$147.34

0.07 (0.05%)

04/30/18
OPCO
04/30/18
NO CHANGE
Target $172
OPCO
Outperform
Honeywell price target lowered to $172 from $180 at Oppenheimer
Oppenheimer analyst Christopher Glynn lowered his price target for Honeywell to $172 from $180 following quarterly results. The analyst reiterates an Outperform rating on the shares.
02/20/18
BARD
02/20/18
NO CHANGE
Target $187
BARD
Outperform
Honeywell weakness a buying opportunity, says Baird
Baird analyst Peter Arment sees positive momentum in 2018 for Honeywell and said he would take advantage of the recent pullback from its recent highs as a buying opportunity. Arment, who sees spinoffs and tax reform resulting in a higher valuation for the shares, reiterated his Outperform rating and $187 price target on Honeywell.
04/09/18
SBSH
04/09/18
NO CHANGE
SBSH
Citi recommends Multi-Industry stocks following year-to-date weakness
Citi analyst Andrew Kaplowitz tells investors to take advantage of the year-to-date weakness in Multi-Industry stocks ahead of the Q1 earnings season. U.S. tax reform, a still strong developing market environment and a slowly improving project-based environment should be catalysts for growth, Kaplowitz writes in a research note. The analyst prefers shares of Honeywell (HON), Gardner Denver (GDI), Ingersoll-Rand (IR), Johnson Controls (JCI), 3M (MMM) and Illinois Tool Works (ITW).
04/11/18
FBCO
04/11/18
NO CHANGE
Target $82
FBCO
Outperform
Slightly higher likelihood Honeywell further evaluates W.R. Grace buyout, says Credit Suisse
Credit Suisse analyst Christopher Parkinson notes that W.R. Grace (GRA) traded higher on unconfirmed potential Honeywell (HON) takeout. While noting the idea has been around for years, the analyst sees "slightly higher" likelihood that Honeywell is further evaluating acquiring W.R. Grace given healthy long-term demand for HPC catalysts, recent speculation that Clariant views W.R. Grace as a primary M&A target, and the recent pullback in the latter's stock price. Parkinson reiterates an Outperform rating and $82 price target on W.R. Grace shares.
ANTM Anthem
$230.86

-1.37 (-0.59%)

04/26/18
BERN
04/26/18
NO CHANGE
Target $332
BERN
Outperform
Anthem price target raised to $332 from $312 at Bernstein
Bernstein analyst Lance Wilkes raised his price target for Anthem to $332 from $312 after the company announced "solid" Q1 results. The analyst reiterates an Outperform rating on the shares.
04/26/18
04/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Buy from Neutral at UBS, to Outperform from Neutral at Macquarie, and to Neutral from Underweight at Atlantic Equities. 2. Boeing (BA) upgraded to Buy from Hold at Societe Generale. 3. Chipotle (CMG) upgraded to Buy from Neutral at BTIG, to Buy from Hold at Canaccord, to Neutral from Sell at Guggenheim, and to Market Perform from Underperform at Cowen. 4. Wex (WEX) upgraded to Buy from Neutral at Citi with analyst Peter Christiansen saying despite rallying 28% in the past six months, the stock should "grind further on continued organic momentum, though importantly on favorable margin dynamics." 5. Anthem (ANTM) upgraded to Overweight from Neutral at JPMorgan with analyst Gary Taylor saying he continues to be comfortable with the near-term trajectory of medical cost trends for the health insurance industry and maintains a long-term preference to own payors over providers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/26/18
JPMS
04/26/18
UPGRADE
JPMS
Overweight
Anthem upgraded to Overweight from Neutral at JPMorgan
04/26/18
JPMS
04/26/18
UPGRADE
Target $287
JPMS
Overweight
Anthem upgraded to Overweight with $287 price target at JPMorgan
JPMorgan analyst Gary Taylor upgraded Anthem to Overweight from Neutral and raised his price target for the shares to $287 from $261. The analyst continues to be comfortable with the near-term trajectory of medical cost trends for the health insurance industry and maintains a long-term preference to own payors over providers. He believes Anthem's Q1 performance "set the stage" for 2018 earnings upside.
WP Worldpay
$81.75

0.81 (1.00%)

05/14/18
BARD
05/14/18
NO CHANGE
Target $94
BARD
Outperform
Worldpay added as a Fresh Pick at Baird
Baird analyst David Koning added Worldpay as a Fresh Pick citing its EBITDA margins, growth, and solid core progression. He believes the current valuation is a good place to be buying as he sees the stock having the potential to be range-bound in the near-term but likely moving into the $90's by year-end. Koning reiterated his Outperform rating and $94 price target on Worldpay shares.
05/10/18
SPHN
05/10/18
NO CHANGE
SPHN
Overweight
Worldpay guidance looks conservative, says Stephens
Stephens analyst Brett Huff thinks Worldpay's stock is off due to FY18 PF EPS guidance questions and Q2 organic constant currency net revenue guide question. However, the analyst believes that there is confusion on sharecount and argues that cost synergy update supports 2H confidence. Conservative guide and market confusion create buying opportunity, he contends, reiterating an Overweight rating on the shares.
03/07/18
NOMU
03/07/18
NO CHANGE
Target $93
NOMU
Buy
Worldpay price target raised to $93 from $83 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Worldpay to $93 saying accelerating organic growth in Vantiv's legacy merchant acquiring business and upbeat management commentary about the business heading into 2018 highlighted last week's Q4 results. The analyst believes the combined company is off to a good start and keeps a Buy rating on the shares.
04/03/18
WEDB
04/03/18
NO CHANGE
WEDB
Activision Blizzard, Cognizant among Wedbush Best Ideas
Wedbush analyst Jesse Bigelow notes that his firm's Best Ideas List is comprised of "the highest rated U.S. Equities, chosen by its analysts and vetted by committee." The list includes Activision Blizzard (ATVI), Cognizant Technology Solutions (CTSH), Electronic Arts (EA), Fiesta Restaurant Group (FRGI), Foot Locker (FL), Norwegian Cruise Line Holdings (NCLH), Proofpoint (PFPT), Regions Financial (RF), and Worldpay (WP).
FB Facebook
$184.30

-2.38 (-1.27%)

05/10/18
UBSW
05/10/18
UPGRADE
Target $48
UBSW
Buy
Match Group upgraded to Buy at UBS
As previously reported, UBS analyst Eric Sheridan upgraded Match Group (MTCH) to Buy from Neutral. The analyst said the recent risks and fears of competition from Facebook (FB) are priced in and its solid Q1 results show the trends for its core brands remain intact. Sheridan maintained his $48 price target on Match Group shares.
05/10/18
BMOC
05/10/18
NO CHANGE
Target $45
BMOC
Outperform
Match Group price target lowered to $45 from $49 at BMO Capital
BMO Capital analyst Daniel Salmon lowered his price target on Match Group (MTCH) to $45, citing the recent sell-off in the stock price after the Facebook (FB) announcement that it is entering into the online dating market. Salmon keeps his Outperform rating however, stating that the valuation discount is too great because he does not expect a "material disruption" to Tinder's use of the Facebook login. The analyst adds that 75% of Tinder users decline to login through Facebook, suggesting that people prefer to keep some space between their social and dating lives.
05/11/18
BNCH
05/11/18
NO CHANGE
Target $182
BNCH
Buy
IAC price target raised to $182 from $176 at Benchmark
Benchmark analyst Daniel Kurnos raised his price target on IAC (IAC) to $182 from $176 after its "strong" quarter, which he said was "headlined by blowout revenue and earnings" from Match (MTCH) and continued strong growth at Angi Homeservices (ANGI). He believes risk to IAC from a Facebook (FB) dating challenge seems largely factored in at current levels, Kurnos added.
05/10/18
DBAB
05/10/18
NO CHANGE
Target $43
DBAB
Buy
Match Group price target raised to $43 from $33 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Match Group (MTCH) to $43 and keeps a Buy rating on the shares. The company's "strong" Q1 results were "overwhelmed' by concerns over Facebook (FB), Walmsley tells investors in a research note. He believes multiple expansion could remain challenged until investors have visibility into Facebook's product and adoption trends.
LEN Lennar
$51.21

-3.06 (-5.64%)

02/23/18
EVER
02/23/18
UPGRADE
EVER
Outperform
Lennar upgraded to Outperform from In Line at Evercore ISI
02/13/18
JPMS
02/13/18
UPGRADE
Target $77
JPMS
Overweight
Lennar reinstated with an Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Rehaut upgraded Lennar (LEN) to Overweight with a $77 price target following a period of restriction. The analyst previously had a Neutral rating on the shares with a $57 price target. Lennar is attractively priced ahead of becoming a "significantly stronger company" as it integrates CalAtlantic (CAA) over the next 12-18 months, Rehaut tells investors in a research note. Lennar will likely have an "uncommonly strong market share" across most of the country following the deal, the analyst contends.
04/05/18
MZHO
04/05/18
NO CHANGE
Target $80
MZHO
Buy
Lennar valuation favorable with more earnings upside ahead, says Mizuho
Mizuho analyst Haendel St. Juste says Lennar's posted "solid" Q1 results on better than expected joint venture income and margins. The analyst sees "even more" earnings upside ahead after Lennar outlined additional fiscal 2018 synergy potential and remained optimistic on the housing backdrop. St. Juste views the current valuation as favorable and maintains a Buy rating on the shares with an $80 price target.
02/23/18
02/23/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. FedEx (FDX) upgraded to Outperform from Market Perform at Bernstein with analyst David Vernon saying he expects revenue and earnings growth to be driven by a strengthening global economy and rising interest rates, the tightening domestic transportation market and demand for B2C delivery. 2. BT Group (BT) upgraded to Buy from Hold at Berenberg. 3. Financial Engines (FNGN) upgraded to Outperform from Market Perform at William Blair with analyst Robert Napoli citing the company's "strong" quarter. 4. Lennar (LEN) upgraded to Outperform from In Line at Evercore ISI. 5. Devon Energy (DVN) upgraded to Buy from Hold at KLR Group with analyst John Gerdes noting that the stock is down over 30% and has significantly underperformed the sector since late January, when he had previously downgraded it. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VMC Vulcan Materials
$127.38

0.58 (0.46%)

12/14/17
RHCO
12/14/17
NO CHANGE
Target $145
RHCO
Buy
Vulcan Materials backlog at 3-year-high, says SunTrust
SunTrust analyst Rohit Seth keeps his Buy rating and $145 price target on Vulcan Materials after hosting investor meetings earlier this week. Seth says that "contrary to the contract award data", visibility for the company is on the rise given that the company's backlogs are now at the highest level in 3 years. The analyst adds that Vulcan Materials is gaining confidence that public recovery is underway.
05/02/18
BOFA
05/02/18
UPGRADE
BOFA
Buy
Vulcan Materials upgraded to Buy from Neutral at BofA/Merrill
05/02/18
BOFA
05/02/18
UPGRADE
Target $134
BOFA
Buy
Vulcan Materials upgraded to Buy, dmeand intact, says at BofA/Merrill
As previously reported, BofA/Merrill upgraded Vulcan Materials to Buy from Neutral and trimmed its price target to $134 from $136. Analyst Timna Tanners said expectations have been reset, valuation is more appropriate, and sees "healthy" construction infrastructure spending benefits in 2019 and beyond.
12/26/17
SBSH
12/26/17
NO CHANGE
Target $144
SBSH
Buy
Citi sees 'great stocking stuffer' in Vulcan Materials settlement
Citi analyst Scott Schrier calls Vulcan Materials' settlement with the Justice Department, which allows for the acquisition of Aggregates USA following 17 divestitures, a "great stocking stuffer." The analyst believes there can be "significant synergies" from the deal due to Vulcan's footprint and distribution network in the Southeast part of the country. He keeps a Buy rating on the shares with a $144 price target.
GOOGL Alphabet Class A
$1,084.87

-21.7 (-1.96%)

05/01/18
ROTH
05/01/18
NO CHANGE
Target $8
ROTH
Buy
Google provides validation to Fitbit digital therapeutics thesis, says Roth Capital
Roth Capital analyst Scott Searle notes that Fitbit (FIT) announced a Google (GOOG; GOOGL) relationship that begins with costs and scale and extends to collaboration and innovation around wearables and its resulting data. The analyst believes Google adds performance and efficiencies as well validates Fitbit's emerging digital therapeutics presence. Searle reiterates a Buy rating and $8 price target on Fitbit's shares.
05/09/18
JPMS
05/09/18
NO CHANGE
JPMS
Overweight
Broadcom co-designed Google's third generation AI processor, says JPMorgan
Google (GOOG, GOOGL) yesterday as its developer conference introduced its third generation deep learning/artificial intelligence processor chip called the Cloud Tensor Processor Unit, JPMorgan analyst Harlan Sur tells investors in a research note. The analyst believes the TPU3 chip was co-designed by Broadcom (AVGO). Further, and just as important, Sur believes Broadcom has won, and is already working with Google on its fourth generation TPU4 processor chip using 7nm manufacturing technology. Broadcom remains the analyst's top pick in semiconductors. He reiterates an Overweight rating on the shares.
05/10/18
MSCO
05/10/18
NO CHANGE
Target $93
MSCO
Equal Weight
Walmart deal for Flipkart more dilutive than anticipated, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman noted that news reports heading up to Walmart's (WMT) deal for a majority stake in Flipkart had predicted a $12B transaction for about 60% of a business generating operating losses in the $1B range. However, the higher than expected magnitude of losses Walmart would absorb in India significantly raises the stakes on the trajectory of its U.S. business and clouds the near-term path, he said. He also questions why the company is investing outside the U.S. market, stating that it could have instead accelerated its third-party marketplace infrastructure, stepped up its partnership with Google Home (GOOG) to better compete with Amazon's (AMZN) Alexa, or intensified domestic investments in price and fulfillment. However, he does add that the deal prevents Amazon, for now, from building an "insurmountable" advantage in the important Indian market. Gutman lowered his price target on Walmart to $93 from $99 after the deal was more dilutive than anticipated and keeps an Equal Weight rating on the shares.
05/01/18
MSCO
05/01/18
NO CHANGE
Target $4
MSCO
Underweight
Fitbit Q1 results likely to be light, says Morgan Stanley
Morgan Stanley analyst Yuuji Anderson said his channel checks found inventory drawdown of Fitbit (FIT) products in-line with typical seasonality, but he noticed limited restocking of Charge 2 and the Alta HR at many retail locations. He thinks the market is prepared for a slight miss to Q1 estimates, but faster declines in legacy products will jeopardize management's FY18 revenue target. He thinks it will become increasingly apparent as the year progress that revenues won't stabilize and cash burn will resume, Anderson tells investors. The analyst, who said the Google (GOOGL) collaboration "does not point to acquisition potential," keeps an Underweight rating and $4 price target on Fitbit shares.
MHK Mohawk
$209.05

-1.63 (-0.77%)

04/30/18
BARD
04/30/18
NO CHANGE
Target $272
BARD
Outperform
Mohawk price target lowered to $272 from $300 at Baird
Baird analyst Timothy Wojs lowered his price target on Mohawk to $272 from $300 following mixed Q1 results. Wojs reiterated his Outperform rating on Mohawk shares, as he thinks the visibility improves despite lowered estimates, which adds conviction to his expectations for accelerating revenue/EBIT growth in the second half of the year.
03/02/18
03/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Home Depot (HD), Lowe's (LOW), Tempur Sealy (TPX), Mohawk (MHK), Lumber Liquidators (LL) and Michaels (MIK) initiated with a Hold at Loop Capital. The firm also started Fortune Brands (FBHS) and Wayfair (W) with a Buy. 2. Aflac (AFL), Lincoln National (LNC), Brighthouse Financial (BHF), MetLife (MET) Unum (UNM), Principal Financial (PFG) and Reinsurance Group (RGA) initiated with a Neutral at UBS. The firm also initiated Voya (VOYA) and FGL Holdings (FG) with a Buy and Torchmark (TMK) and American Equity (AEL) with a Sell. 3. HP Enterprise (HPE) initiated with a Neutral at JPMorgan. 4. Caterpillar (CAT), Deere (DE), United Rentals (URI) and Wabco (WBC) initiated with an Overweight, Oshkosh (OSK), Terex (TEX), Cummins (CMI), CNH Industrial (CNHI) and REV Group (REVG) initiated with an Equal Weight and Paccar (PCAR) and Agco (AGCO) initiated with an Underweight at Morgan Stanley. 5. Conatus (CNAT) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/01/18
RBCM
05/01/18
NO CHANGE
Target $284
RBCM
Outperform
Mohawk price target lowered to $284 from $310 at RBC Capital
RBC Capital analyst Michael Eisen lowered his price target on Mohawk to $284, saying that while the company's Q1 results were inline with expectations, the outlook for FY18 regarding accelerating revenue growth and margin expansion was absent. The analyst further notes inefficiencies of new facilities and intensifying startup/input costs but keeps his Outperform rating, noting that the recent weakness does not realize the company's long-term growth prospects.
04/27/18
LOOP
04/27/18
NO CHANGE
Target $227
LOOP
Hold
Mohawk price target lowered to $227 from $261 at Loop Capital
Loop Capital analyst Laura Champine lowered her price target for Mohawk Industries to $227 citing a weaker margin outlook following the company's Q1 results. The analyst reduced her long term sales growth expectation to 5% from 6% on the rise in interest rates. She reiterates a Hold rating on Mohawk.
STZ Constellation Brands
$221.75

-0.05 (-0.02%)

04/03/18
04/03/18
DOWNGRADE
Target $228

Hold
Constellation Brands downgraded to Hold on valuation at Stifel
As previously reported, Stifel analyst Mark Swartzberg downgraded Constellation Brands to Hold from Buy, calling the change a valuation call. While he does not think forecasts are too high, he does think the market is pricing in substantial beats, which he sees as being hard to achieve, Swartzberg tells investors. After considering the valuation further, the analyst lowered his price target on Constellation Brands shares to $228 from $245.
04/16/18
MSCO
04/16/18
NO CHANGE
Target $262
MSCO
Overweight
Constellation's strong long-term beer prospects mispriced, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian believes the consensus view is not appropriately reflecting Constellation Brands' strong long-term growth prospects in beer. Following the company's better than expected FY19 EPS guidance, he sees the prospect of positive EPS revisions and remains bullish on Constellation shares at current levels. Mohsenian reiterates an Overweight rating and $262 price target on Constellation Brands.
04/03/18
ARGS
04/03/18
NO CHANGE
Target $260
ARGS
Buy
Constellation Brands price target raised to $260 from $250 at Argus
Argus analyst John Staszak raised his price target on Constellation Brands to $260, citing the impact of the recent additions to the company's brand portfolio and an increase in its share of the U.S. beer market. The analyst also notes the company's above-average margins, attractive valuation relative to peers' multiples, and expectations of continued benefits from the economies of scale. Staszak keeps his Buy rating on Constellation Brands.
05/09/18
JPMS
05/09/18
DOWNGRADE
Target $52
JPMS
Neutral
Monster Beverage downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Andrea Teixeira downgraded Monster Beverage (MNST) to Neutral and lowered her price target for the shares to $52 from $67. The analyst sees a "difficult road ahead" for the company following its Q1 results. She believes the shares will "remain challenged" until margins improve. Teixeira prefers top picks Estee Lauder (EL) and Constellation Brands (STZ) for Home and Personal Care exposure.
BAX Baxter
$70.45

-0.76 (-1.07%)

02/02/18
COWN
02/02/18
NO CHANGE
Target $78
COWN
Market Perform
Baxter guidance reaction unwarranted, says Cowen
Cowen analyst Joshua Jennings noted Baxter's Q2 guidance implied a headwind to operating margins and the shares sold off. The analyst believes the selloff was an overreaction and unwarranted, though, as he believes the guidance could be conservative and it will not disrupt the company's multiyear margin progress. Jennings maintained his Market Perform rating and raised his price target to $78 from $68 on Baxter shares.
01/03/18
EVER
01/03/18
INITIATION
Target $71
EVER
Outperform
Baxter initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Baxter with an Outperform rating and $71 price target. The analyst thinks Baxter should be able to meet or beat 2018 Street expectations and its balance sheet strength gives it over $10B in capacity for M&A, he tells investors.
02/20/18
DBAB
02/20/18
UPGRADE
Target $80
DBAB
Buy
Baxter upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Kristen Stewart upgraded Baxter International to Buy and raised her price target for the shares to $80 from $50. The analyst expects management to execute well and she views the company's 2018 guidance as achievable, if not conservative. She sees the May analyst day as an upcoming catalyst and believes the stock deserves a premium valuation.
05/14/18
ARGS
05/14/18
NO CHANGE
ARGS
Hold
Baxter pullback would warrant a potential upgrade, says Argus
Argus analyst John Eade kept his Hold rating on Baxter after the company's Q1 earnings beat and raised FY18 outlook, saying he would consider an upgrade if the stock price pulled back to the mid-$60's range. The analyst notes that Baxter has "substantially improved profitability in recent quarters" even as it continues to rely on M&A as a source of revenue and margin growth. Eade adds that while the company's Renal and Hospital Products segments are mature businesses, the company's balance sheet is clean, and the management's recent dividend raise is indicative of its confidence in Baxter's prospects.

TODAY'S FREE FLY STORIES

SABR

Sabre

$25.17

0.27 (1.08%)

08:57
11/14/18
11/14
08:57
11/14/18
08:57
Conference/Events
Sabre to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

ECA

Encana

$8.10

-0.315 (-3.75%)

, AAPL

Apple

$192.23

-1.925 (-0.99%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Options
Notable open interest changes for November 14th »

Tuesday's total…

ECA

Encana

$8.10

-0.315 (-3.75%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

GE

General Electric

$8.61

0.625 (7.83%)

M

Macy's

$35.77

-1.27 (-3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

PETQ

PetIQ

$31.27

-1.77 (-5.36%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Recommendations
PetIQ analyst commentary  »

PetIQ price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BATRA

Liberty Braves Group

$25.06

0.15 (0.60%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FWONA

Formula One Group

$31.01

0.47 (1.54%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Formula One Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BATRK

Liberty Braves

$24.88

0.02 (0.08%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

08:54
11/14/18
11/14
08:54
11/14/18
08:54
Conference/Events
Federal Reserve Bank of Dallas president participates in a discussion »

Federal Reserve Bank of…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

08:53
11/14/18
11/14
08:53
11/14/18
08:53
Recommendations
Qorvo, Lumentum, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

LITE

Lumentum

$38.95

1.445 (3.85%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ON

ON Semiconductor

$17.35

0.54 (3.21%)

, ST

Sensata

$46.37

0.3 (0.65%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
ON Semiconductor, Sensata analyst commentary  »

Morgan Stanley says auto…

ON

ON Semiconductor

$17.35

0.54 (3.21%)

ST

Sensata

$46.37

0.3 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 08

    May

CELC

Celcuity

$27.94

-0.13 (-0.46%)

, PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Recommendations
Celcuity, Puma Biotechnology analyst commentary  »

Celcuity price target…

CELC

Celcuity

$27.94

-0.13 (-0.46%)

PBYI

Puma Biotechnology

$22.03

-0.13 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 03

    Dec

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

, GE

General Electric

$8.61

0.625 (7.83%)

08:52
11/14/18
11/14
08:52
11/14/18
08:52
Syndicate
Baker Hughes 92M share secondary offering by GE prices at $23.00 »

Baker Hughes, a GE…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

GE

General Electric

$8.61

0.625 (7.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

BHGE

Baker Hughes

$23.80

0.17 (0.72%)

08:51
11/14/18
11/14
08:51
11/14/18
08:51
Syndicate
Baker Hughes 92M share Secondary priced at $23.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

PCG

PG&E

$32.70

-0.25 (-0.76%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Recommendations
PG&E analyst commentary  »

PG&E price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.78

0.55 (0.86%)

08:50
11/14/18
11/14
08:50
11/14/18
08:50
Conference/Events
Economic Club of New York to hold a luncheon meeting »

Luncheon Meeting with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

08:50
11/14/18
11/14
08:50
11/14/18
08:50
General news
Treasury Action: yields probed higher »

Treasury Action: yields…

08:49
11/14/18
11/14
08:49
11/14/18
08:49
Conference/Events
Federal Reserve Vice Chairman speaks before House Financial Services Committee »

Federal Reserve Vice…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

08:48
11/14/18
11/14
08:48
11/14/18
08:48
Recommendations
Qorvo analyst commentary  »

Qorvo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRSN

Mersana Therapeutics

$6.04

0.19 (3.25%)

08:47
11/14/18
11/14
08:47
11/14/18
08:47
Upgrade
Mersana Therapeutics rating change  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$31.09

-0.495 (-1.57%)

08:46
11/14/18
11/14
08:46
11/14/18
08:46
Conference/Events
The FDA holds a joint committee meeting »

The Anesthetic &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 16

    Nov

PGR

Progressive

$71.63

-0.28 (-0.39%)

08:45
11/14/18
11/14
08:45
11/14/18
08:45
Hot Stocks
Progressive reports October EPS (6c) vs. 27c last year »

Reports October net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

, APRN

Blue Apron

$1.22

-0.03 (-2.40%)

08:45
11/14/18
11/14
08:45
11/14/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

HCLP

Hi-Crush Partners

$6.35

0.15 (2.42%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

BPL

Buckeye Partners

$31.66

-0.535 (-1.66%)

ECYT

Endocyte

$23.59

0.03 (0.13%)

AAXJ

iShares MSCI All Country Asia Ex Japan

$64.36

1.13 (1.79%)

EWZ

MSCI Brazil Index

$38.32

-0.6 (-1.54%)

NEPT

Neptune Wellness

$3.20

-0.14 (-4.19%)

CRON

Cronos Group

$8.29

-0.15 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

08:45
11/14/18
11/14
08:45
11/14/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar was…

08:45
11/14/18
11/14
08:45
11/14/18
08:45
General news
Breaking General news story  »

Federal Reserve Vice…

UEIC

Universal Electronics

$33.29

-1.99 (-5.64%)

08:44
11/14/18
11/14
08:44
11/14/18
08:44
Upgrade
Universal Electronics rating change  »

Universal Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.